We are live on
!
Find out more
DA
DSC Advisors Portfolio holdings
AUM
$11M
1-Year Est. Return
5.88%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$176M
AUM Growth
+$11.8M
(+7.2%)
Cap. Flow
+$145M
Cap. Flow
% of AUM
82.21%
Top 10 Holdings %
Top 10 Hldgs %
67.24%
Holding
79
New
13
Increased
10
Reduced
24
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.47M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$4.12M |
| 3 |
HCA Healthcare
HCA
|
+$4.11M |
| 4 |
Liberty Global Class A
LBTYA
|
+$2.84M |
| 5 |
SWFT
Swift Transportation Company
SWFT
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$5.7M |
| 2 |
Biogen
BIIB
|
+$4.41M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$3.02M |
| 4 |
DVAX
Dynavax Technologies
DVAX
|
+$1.63M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.65% |
| 2 | Financials | 21.92% |
| 3 | Materials | 6.36% |
| 4 | Communication Services | 5.46% |
| 5 | Technology | 4.88% |
Similar funds
RJTCONH
HSC
BGC
ACM
AG
RVM
JDR
KM
DSC Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, DSC Advisors held 79 positions worth $176M, up 7.2% from $165M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
DSC Advisors deployed $145M of net new capital in Q4 2016, opening 13 new positions and adding to 10 existing holdings. Its largest new stake was Liberty Global Class A: 90,000 shares worth $1.91M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 54% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Foamix Pharmaceuticals Ltd. Ordinary Shares, an estimated $1.01M trimmed.
- DSC Advisors's largest Q4 2016 buy was Liberty Global Class A: 90,000 shares worth $1.91M.
- DSC Advisors added most to Aetna Inc in Q4 2016, an estimated $4.47M increase.
- DSC Advisors's biggest Q4 2016 reduction was Foamix Pharmaceuticals Ltd. Ordinary Shares, cutting an estimated $1.01M.
- DSC Advisors fully exited Elevance Health in Q4 2016, selling an estimated $5.7M.
- DSC Advisors's ten largest holdings make up 67% of its $176M portfolio in Q4 2016.
- DSC Advisors opened 13 new positions and closed 26 in Q4 2016.
- DSC Advisors's portfolio value rose 7.2% quarter-over-quarter to $176M.
Based on DSC Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.